L. McIntosh

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163

Susan Ellard, Mark Clemons, Karen A. Gelmon et al. · Journal of Clinical Oncology · 2009 · 261 citations

Medicine, Oncology, Pharmacology +16

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Brian Thiessen, Clinton F. Stewart, Ming‐Sound Tsao et al. · Cancer Chemotherapy and Pharmacology · 2009 · 205 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study.

M. Christine Cripps, A Figueredo, Amit M. Oza et al. · PubMed · 2002 · 97 citations

Medicine, Oncology, Pharmacology +11

A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study

Michael Crump, David W. Hedley, Suzanne Kamel‐Reid et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 83 citations

Medicine, Oncology, Pharmacology +17

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆

Amit M. Oza, Laurie Elit, K. Swenerton et al. · Gynecologic Oncology · 2003 · 75 citations

Medicine, Gynecology, Oncology +12